(19)
(11) EP 2 477 658 A2

(12)

(88) Date of publication A3:
15.09.2011

(43) Date of publication:
25.07.2012 Bulletin 2012/30

(21) Application number: 10817555.5

(22) Date of filing: 16.09.2010
(51) International Patent Classification (IPC): 
A61K 39/42(2006.01)
C12N 5/07(2010.01)
C07K 16/10(2006.01)
A61P 31/18(2006.01)
(86) International application number:
PCT/US2010/002515
(87) International publication number:
WO 2011/034582 (24.03.2011 Gazette 2011/12)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 05.10.2009 US 248796 P
16.09.2009 US 272349 P

(71) Applicants:
  • Duke University
    Durham, NC 27708-0083 (US)
  • The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services
    Rockville, MD 20892-7660 (US)
  • The Feinstein Institute for Medical Research
    Manhasset, NY 11030 (US)

(72) Inventors:
  • HAYNES, Barton, F.
    Durham NC 27708-0083 (US)
  • TOMARAS, Georgia
    Durham NY 27708-0083 (US)
  • SHEN, Shaunna
    Durham NY 27708-0083 (US)
  • DIMITROV, Dimiter, S.
    Frederick, MD 21702 (US)
  • ZHU, Zhongyu
    Frederick MD 21702 (US)
  • HWANG, Kwan-Ki
    Durham NC 27708-0083 (US)
  • CHIORAZZI, Nicholas
    NY 11030 (US)

(74) Representative: Atkinson, Peter Birch et al
Marks & Clerk LLP 1 New York Street
Manchester, M1 4HD
Manchester, M1 4HD (GB)

   


(54) HIV-1 ANTIBODIES